m6A-centered Disease Response Information
General Information of the Disease (ID: M6ADIS0027)
Name |
Laryngeal cancer
|
||||
---|---|---|---|---|---|
ICD |
ICD-11: 2C23
|
Full List of Target Gene(s) of This m6A-centered Disease Response
ATPase family AAA domain-containing protein 3A (ATAD3A)
In total 1 item(s) under this target gene | ||||
Experiment 1 Reporting the m6A-centered Disease Response by This Target Gene | [1] | |||
Response Summary | RBM15-mediated m6A modification of TMBIM6 mRNA enhanced TMBIM6 stability through IGF2BP3-dependent. Laryngeal squamous cell cancer cells were transfected with shRBM15 lentivirus for 48h, and the qRT-PCR data indicated that the mRNA levels of CPNE5, TMBIM6, and ATPase family AAA domain-containing protein 3A (ATAD3A) decreased after RBM15 knockdown. | |||
Responsed Disease | Laryngeal cancer [ICD-11: 2C23] | |||
Target Regulator | RNA-binding motif protein 15 (RBM15) | WRITER | ||
Target Regulation | Up regulation | |||
Cell Process | RNA stability | |||
Cell apoptosis | ||||
In-vitro Model | AMC-HN-8 | Laryngeal squamous cell carcinoma | Homo sapiens | CVCL_5966 |
NHBEC (Normal human bronchial epithelial cell) | ||||
Tu 177 | Laryngeal squamous cell carcinoma | Homo sapiens | CVCL_4913 | |
Tu 212 | Head and neck squamous cell carcinoma | Homo sapiens | CVCL_4915 | |
In-vivo Model | For tumor growth studies, whether in vivo RBM15 knockdown/overexpression experiments or in vivo rescue experiments, each group included six mice. Each mouse was injected with 100 uL of lentivirus-transfected tumor cells. | |||
Bax inhibitor 1 (TMBIM6)
In total 2 item(s) under this target gene | ||||
Experiment 1 Reporting the m6A-centered Disease Response by This Target Gene | [1] | |||
Response Summary | RBM15-mediated m6A modification of Bax inhibitor 1 (TMBIM6) mRNA enhanced TMBIM6 stability through IGF2BP3-dependent. Laryngeal squamous cell cancer cells were transfected with shRBM15 lentivirus for 48h, and the qRT-PCR data indicated that the mRNA levels of CPNE5, TMBIM6, and ATAD3A decreased after RBM15 knockdown. | |||
Responsed Disease | Laryngeal cancer [ICD-11: 2C23] | |||
Target Regulator | Insulin-like growth factor 2 mRNA-binding protein 3 (IGF2BP3) | READER | ||
Target Regulation | Up regulation | |||
Cell Process | RNA stability | |||
Cell apoptosis | ||||
In-vitro Model | AMC-HN-8 | Laryngeal squamous cell carcinoma | Homo sapiens | CVCL_5966 |
NHBEC (Normal human bronchial epithelial cell) | ||||
Tu 177 | Laryngeal squamous cell carcinoma | Homo sapiens | CVCL_4913 | |
Tu 212 | Head and neck squamous cell carcinoma | Homo sapiens | CVCL_4915 | |
In-vivo Model | For tumor growth studies, whether in vivo RBM15 knockdown/overexpression experiments or in vivo rescue experiments, each group included six mice. Each mouse was injected with 100 uL of lentivirus-transfected tumor cells. | |||
Experiment 2 Reporting the m6A-centered Disease Response by This Target Gene | [1] | |||
Response Summary | RBM15-mediated m6A modification of Bax inhibitor 1 (TMBIM6) mRNA enhanced TMBIM6 stability through IGF2BP3-dependent. Laryngeal squamous cell cancer cells were transfected with shRBM15 lentivirus for 48h, and the qRT-PCR data indicated that the mRNA levels of CPNE5, TMBIM6, and ATAD3A decreased after RBM15 knockdown. | |||
Responsed Disease | Laryngeal cancer [ICD-11: 2C23] | |||
Target Regulator | RNA-binding motif protein 15 (RBM15) | WRITER | ||
Target Regulation | Up regulation | |||
Cell Process | RNA stability | |||
Cell apoptosis | ||||
In-vitro Model | AMC-HN-8 | Laryngeal squamous cell carcinoma | Homo sapiens | CVCL_5966 |
NHBEC (Normal human bronchial epithelial cell) | ||||
Tu 177 | Laryngeal squamous cell carcinoma | Homo sapiens | CVCL_4913 | |
Tu 212 | Head and neck squamous cell carcinoma | Homo sapiens | CVCL_4915 | |
In-vivo Model | For tumor growth studies, whether in vivo RBM15 knockdown/overexpression experiments or in vivo rescue experiments, each group included six mice. Each mouse was injected with 100 uL of lentivirus-transfected tumor cells. | |||
Copine-5 (CPNE5)
In total 1 item(s) under this target gene | ||||
Experiment 1 Reporting the m6A-centered Disease Response by This Target Gene | [1] | |||
Response Summary | RBM15-mediated m6A modification of TMBIM6 mRNA enhanced TMBIM6 stability through IGF2BP3-dependent. Laryngeal squamous cell cancer cells were transfected with shRBM15 lentivirus for 48h, and the qRT-PCR data indicated that the mRNA levels of Copine-5 (CPNE5), TMBIM6, and ATAD3A decreased after RBM15 knockdown. | |||
Responsed Disease | Laryngeal cancer [ICD-11: 2C23] | |||
Target Regulator | RNA-binding motif protein 15 (RBM15) | WRITER | ||
Target Regulation | Up regulation | |||
Cell Process | RNA stability | |||
Cell apoptosis | ||||
In-vitro Model | AMC-HN-8 | Laryngeal squamous cell carcinoma | Homo sapiens | CVCL_5966 |
NHBEC (Normal human bronchial epithelial cell) | ||||
Tu 177 | Laryngeal squamous cell carcinoma | Homo sapiens | CVCL_4913 | |
Tu 212 | Head and neck squamous cell carcinoma | Homo sapiens | CVCL_4915 | |
In-vivo Model | For tumor growth studies, whether in vivo RBM15 knockdown/overexpression experiments or in vivo rescue experiments, each group included six mice. Each mouse was injected with 100 uL of lentivirus-transfected tumor cells. | |||
KCNQ1 opposite strand/antisense transcript 1 (KCNQ1OT1)
In total 2 item(s) under this target gene | ||||
Experiment 1 Reporting the m6A-centered Disease Response by This Target Gene | [2] | |||
Response Summary | ALKBH5 mediates KCNQ1 opposite strand/antisense transcript 1 (KCNQ1OT1) expression via an m6A-YTHDF2-dependent manner and KCNQ1OT1 could directly bind to HOXA9 to further regulate the proliferation, invasion and metastasis of laryngeal squamous cell carcinoma cells. | |||
Responsed Disease | Laryngeal cancer [ICD-11: 2C23] | |||
Target Regulator | YTH domain-containing family protein 2 (YTHDF2) | READER | ||
Target Regulation | Up regulation | |||
Cell Process | Cell proliferation and metastasis | |||
In-vitro Model | AMC-HN-8 | Laryngeal squamous cell carcinoma | Homo sapiens | CVCL_5966 |
HOK | Normal | Hexagrammos otakii | CVCL_YE19 | |
Tu 212 | Head and neck squamous cell carcinoma | Homo sapiens | CVCL_4915 | |
In-vivo Model | 1 × 106 (100 ul) cells of infected and uninfected by lentiviral were, respectively, injected subcutaneously into nude mice which divided randomly into scramble group and shKCNQ1OT1-1 group. | |||
Experiment 2 Reporting the m6A-centered Disease Response by This Target Gene | [2] | |||
Response Summary | ALKBH5 mediates KCNQ1 opposite strand/antisense transcript 1 (KCNQ1OT1) expression via an m6A-YTHDF2-dependent manner and KCNQ1OT1 could directly bind to HOXA9 to further regulate the proliferation, invasion and metastasis of laryngeal squamous cell carcinoma cells. | |||
Responsed Disease | Laryngeal cancer [ICD-11: 2C23] | |||
Target Regulator | RNA demethylase ALKBH5 (ALKBH5) | ERASER | ||
Target Regulation | Up regulation | |||
Cell Process | Cell proliferation and metastasis | |||
In-vitro Model | AMC-HN-8 | Laryngeal squamous cell carcinoma | Homo sapiens | CVCL_5966 |
HOK | Normal | Hexagrammos otakii | CVCL_YE19 | |
Tu 212 | Head and neck squamous cell carcinoma | Homo sapiens | CVCL_4915 | |
In-vivo Model | 1 × 106 (100 ul) cells of infected and uninfected by lentiviral were, respectively, injected subcutaneously into nude mice which divided randomly into scramble group and shKCNQ1OT1-1 group. | |||
References